トピックス
Home > トピックス > 研究成果 > 2022年

2022年

  1. Kodama T, Kamei K, Kichikawa Y: Allergic Bronchopulmonary Mycosis Due to Schizophyllum commune Presented as a Lung Mass. Arch Bronconeumol, in press.
  2. Kurihara E, Takeshita K, Tanaka S, Takeuchi N, Ohkusu M, Hishiki H, Ishiwada N. Clinical and bacteriological analysis of pediatric pneumococcal meningitis after 13-valent pneumococcal conjugate vaccine introduction in Japan. Microbiology Spectrum, 2022 in press.
  3. Mori M, Ueki Y, Ishiwada N. Impact of Janus kinase inhibitors on antibody response to 13-valent pneumococcal conjugate vaccine in patients with rheumatoid arthritis. Modern Rheumatology, 2022 in press.
  4. Van Braeckel E, Page I, Davidsen J, Laursen C, Agarwal R, Alastruey-Izquierdo A, Barac A, Cadranel J, Chakrabarti A, Cornely O, Denning D, Flick H, Gangneux JP, Godet C, Hayashi Y, Hennequin C, Hoenigl M, Irfan M, Izumikawa K, Koh WJ, Kosmidis C. Lange C, Lamprecht B, Laurent F, Munteanu O, Oladele R, Patterson T, Watanabe A, Salzer H: Treatment outcome definitions in chronic pulmonary aspergillosis: a CPAnet consensus statement. Eur Respir J, in press.
  5. Arasaki R, Tanaka S, Okawa K, Tanaka Y, Inoue T, Kobayashi S, Maruyama-Inoue M, Yamaguchi T, Muraosa Y, Kamei K, Kadonosono K: Endophthalmitis outbreak caused by Fusarium oxysporum after cataract surgery. Am J Ophthalmol Case Rep 26: 101397, 2022.
  6. Hase I, Kagatani J, Suzuki S, Yoshida S, Sakamoto K, Maitani F, Horinouchi H, Kamei K, Tateno H: Successfully treated bronchopulmonary oxalosis caused by Aspergillus tubingensis in a non-neutropenic patient: A case report and review of the literature. J Infect Chemother 28(2): 299-303, 2022.
  7. Hoshino T, Nishima D, Enseki M, Umehara T, Fukasawa C, Ishiwada N. Pediatric parapneumonic effusion/pleural empyema in Japan: A nationwide survey. Pediatr Infect Dis J, 2022 Jan 1;41(1):20-23.
  8. Katsuta T, Shimizu N, Okada K, Taya K, Nakano T, Kamiya H, Amou K, Ishiwada N, Iwata S, Oshiro M, Okabe N, Kira R, Korematsu S, Suga S, Tsugawa T, Nishimura N, Hishiki H, Fujioka M, Hosoya M, Mizuno Y, Mine M, Miyairi I, Miyazaki C, Morioka I, Morishima T, Yoshikawa T, Wada T, Azuma H, Kusuhara K, Ouchi K, Saitoh A, Moriuchi H. The clinical characteristics of pediatric coronavirus disease 2019 in 2020 in Japan. Pediatr Int. 2022 Jan;64(1):e14912.
  9. Khalifa HO, Hubka V, Watanabe A, Nagi M, Miyazaki Y, Yaguchi T, Kamei K: Prevalence of Antifungal Resistance, Genetic Basis of Acquired Azole and Echinocandin Resistance, and Genotyping of Candida krusei recovered from an International Collection. Antimicrob Agents Chemother, 66(2): e0185621, 2022.
  10. Khalifa HO, Watanabe A, Kamei K: Azole and Echinocandin Resistance Mechanisms and Genotyping of Candida tropicalis in Japan: Cross-Boundary Dissemination and Animal-Human Transmission of C. tropicalis Infection. Clin Microbiol Infect, 28(2): 302.e5-302.e8, 2022.
  11. Kodama T, Ueno K, Kondo T, Morozumi Y, Kato K, Nagai S, Shibuya K, Sasakawa C. Spectrophotometric microplate assay for titration and neutralization of avian nephritis virus based on the virus cytopathicity. J Virol Methods, 2022 299:114303.
  12. Miyazawa H, Matsuda Y, Sakai S, Kamei K, Wada T: Mesenteric abscess caused by coinfection with Bacillus Calmette-Guérin and Phialemonium sp. in chronic granulomatous disease. IDCases, 27: e01375, 2022.
  13. Nagasawa K, Ishiwada N. Disease burden of respiratory syncytial virus infection in the pediatric population in Japan. J Infect Chemother. 2022 Feb;28(2):146-157.
  14. Pontes L, Gualtieri Beraquet CA, Arai T, Watanabe A, Moretti ML, Schreiber AZ: Selection of Aspergillus fumigatus isolates carrying the G448S substitution in CYP 51A gene after long-term treatment with voriconazole in an immunocompromised patient. Med Mycol Case Rep 36: 5-9, 2022.
  15. Takamatsu A, Yaguchi T, Tagashira Y, Watanabe A, Honda H: Nocardiosis in Japan: a multicentric retrospective cohort study. Antimicrob Agents Chemother, 66(2): e01890-21, 2022.
  16. Takeda K, Suzuki J, Watanabe A, Narumoto O, Kawashima M, Sasaki Y, Nagai H, kamei K, Matsui H: Non-fumigatus Aspergillus infection associated with a negative Aspergillus precipitin test in patients with chronic pulmonary aspergillosis. J Clin Microbiol, 60(2): e0201821, 2022.
  17. Takeda K, Suzuki J, Watanabe A, Sekiguchi R, Sano T, Narumoto O, Kawashima M, Fukami T, Sasaki Y, Tamura A, Nagai H, Matsui H, Kamei K: The accuracy and clinical impact of the morphological identification of Aspergillus species in the age of cryptic species: A single-centre study. Mycoses 65(2):164-170, 2022.
  18. Takeshita K, Ishiwada N, Takeuchi N, Ohkusu M, Ohata M, Hino M, Hishiki H, Takeda Y, Sakaida E, Takahashi Y, Shimojo N, Hamada H. Immunogenicity and safety of routine 13-valent pneumococcal conjugate vaccination outside recommended age range in patients with hematological malignancies and solid tumors. Vaccine. 2022 Feb 23;40(9):1238-1245.
  19. Takeshita K, Takeuchi N, Ohkusu M, Hishiki H, Shiko Y, Kawasaki Y, Chang B, Ishiwada N. Epidemiological characteristics in serotype 24 paediatric invasive pneumococcal disease according to an 11-year population-based study in Japan. Epidemiol Infect. 2022 Feb 28;150:e66.
  20. Toh-E A, Ohkusu M, Ishiwada N, Watanabe A, Kamei K: Genetic system underlying responses of Cryptococcus neoformans to cadmium. Curr Genet,68(1): 125-141, 2022.
  21. Watanabe E, Akamatsu T, Omori M, Kato M, Takeuchi N, Ishiwada N, Nishimura R, Hishiki H, Fujimura L, Ito C, Hatano M. Recombinant thrombomodulin attenuates hyper-inflammation and glycocalyx damage in a murine model of Streptococcus pneumoniae-induced sepsis. Cytokine, 2022 Jan;149:155723.